Erratum: Clustered epitopes within the Gag-Pol fusion protein DNA vaccine enhance immune responses and protection against challenge with recombinant vaccinia viruses expressing HIV-1 Gag and Pol antigens (Virology (2005) 332 (467-479) DOI: 10.1016/j.virol.2004.09.043);Clustered epitopes within the Gag-Pol fusion protein DNA vaccine enhance immune responses and protection against challenge with recombinant vaccinia viruses expressing HIV-1 Gag and Pol antigens

Virology

Volumn 332, Issue 2, 2005, Pages 467-479

  Bolesta, Elizabeth ^a   Gzyl, Jaroslaw ^a   Wierzbicki, Andrzej ^a   Kmieciak, Dariusz ^b   Kowalczyk, Aleksandra ^a   Kaneko, Yutaro ^c   Srinivasan, Alagarsamy ^d   Kozbor, Danuta ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c KINKI UNIVERSITY   (Japan)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

DNA vaccine; Gag and Pol proteins; HIV 1; Th and CTL responses

Indexed keywords

DNA VACCINE; GAG POL FUSION PROTEIN DNA VACCINE; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; POL PROTEIN; UNCLASSIFIED DRUG; VACCINIA VACCINE;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CODON; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; FRAMESHIFT MUTATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; TRANSGENIC MOUSE; VACCINIA VIRUS; VIRUS RECOMBINANT;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MUS MUSCULUS; VACCINIA VIRUS;

EID: 13144293070     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2005.03.008     Document Type: Erratum

References (54)

1. T.W. Baba, Y.S. Jeong, D. Pennick, R. Bronson, M.F. Greene, and R.M. Ruprecht Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques Science 267 5205 1995 1820 1825
2. D.H. Barouch, and N.L. Letvin DNA vaccination for HIV-1 and SIV Intervirology 43 4-6 2000 282 287
3. R.B. Belshe, D.P. Bolognesi, M.L. Clements, L. Corey, R. Dolin, J. Mestecky, M. Mulligan, D. Stablein, and P. Wright HIV infection in vaccinated volunteers JAMA 272 6 1994 431
4. I.M. Belyakov, M.A. Derby, J.D. Ahlers, B.L. Kelsall, P. Earl, B. Moss, W. Strober, and J.A. Berzofsky Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge Proc. Natl. Acad. Sci. U.S.A. 95 4 1998 1709 1714
5. N.F. Bernard, C.M. Yannakis, J.S. Lee, and C.M. Tsoukas Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons J. Infect. Dis. 179 3 1999 538 547
6. M.R. Betts, J.F. Krowka, T.B. Kepler, M. Davidian, C. Christopherson, S. Kwok, L. Louie, J. Eron, H. Sheppard, and J.A. Frelinger Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors AIDS Res. Hum. Retroviruses 15 13 1999 1219 1228
7. W.M. Bogers, H. Niphuis, P. ten Haaft, J.D. Laman, W. Koornstra, and J.L. Heeney Protection from HIV-1 envelope-bearing chimeric simian immunodeficiency virus (SHIV) in rhesus macaques infected with attenuated SIV: consequences of challenge Aids 9 12 1995 F13 F18
8. P. Borrow, H. Lewicki, B.H. Hahn, G.M. Shaw, and M.B. Oldstone Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection J. Virol. 68 9 1994 6103 6110
9. P.L. Earl, S. Koenig, and B. Moss Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses J. Virol. 65 1 1991 31 41
10. D.L. Ellenberger, B. Li, L.D. Lupo, S.M. Owen, J. Nkengasong, M.S. Kadio-Morokro, J. Smith, H. Robinson, M. Ackers, A. Greenberg, T. Folks, and S. Butera Generation of a consensus sequence from prevalent and incident HIV-1 infections in West Africa to guide AIDS vaccine development Virology 302 1 2002 155 163
11. D.T. Evans, D.H. O'Connor, P. Jing, J.L. Dzuris, J. Sidney, J. da Silva, T.M. Allen, H. Horton, J.E. Venham, R.A. Rudersdorf, T. Vogel, C.D. Pauza, R.E. Bontrop, R. DeMars, A. Sette, A.L. Hughes, and D.I. Watkins Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef Nat. Med. 5 11 1999 1270 1276
12. T.G. Evans, M.C. Keefer, K.J. Weinhold, M. Wolff, D. Montefiori, G.J. Gorse, B.S. Graham, M.J. McElrath, M.L. Clements-Mann, M.J. Mulligan, P. Fast, M.C. Walker, J.L. Excler, A.M. Duliege, and J. Tartaglia A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers J. Infect. Dis. 180 2 1999 290 298
13. T.M. Fu, L.M. Mylin, T.D. Schell, I. Bacik, G. Russ, J.W. Yewdell, J.R. Bennink, and S.S. Tevethia An endoplasmic reticulum-targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 large T antigen cytotoxic T-lymphocyte epitope J. Virol. 72 2 1998 1469 1481
14. H. Gahery-Segard, G. Pialoux, B. Charmeteau, S. Sermet, H. Poncelet, M. Raux, A. Tartar, J.P. Levy, H. Gras-Masse, and J.G. Guillet Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine J. Virol. 74 4 2000 1694 1703
15. A. Gallimore, H. Hengartner, and R. Zinkernagel Hierarchies of antigen-specific cytotoxic T-cell responses Immunol. Rev. 164 1998 29 36
16. B. Gaschen, J. Taylor, K. Yusim, B. Foley, F. Gao, D. Lang, V. Novitsky, B. Haynes, B.H. Hahn, T. Bhattacharya, and B. Korber Diversity considerations in HIV-1 vaccine selection Science 296 5577 2002 2354 2360
17. P.J. Goulder, R.E. Phillips, R.A. Colbert, S. McAdam, G. Ogg, M.A. Nowak, P. Giangrande, G. Luzzi, B. Morgan, A. Edwards, A.J. McMichael, and S. Rowland-Jones Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS Nat. Med. 3 2 1997 212 217
18. P.J. Goulder, C. Brander, Y. Tang, C. Tremblay, R.A. Colbert, M.M. Addo, E.S. Rosenberg, T. Nguyen, R. Allen, A. Trocha, M. Altfeld, S. He, M. Bunce, R. Funkhouser, S.I. Pelton, S.K. Burchett, K. McIntosh, B.T. Korber, and B.D. Walker Evolution and transmission of stable CTL escape mutations in HIV infection Nature 412 6844 2001 334 338
19. G. Haas, A. Samri, E. Gomard, A. Hosmalin, J. Duntze, J.M. Bouley, H.G. Ihlenfeldt, C. Katlama, and B. Autran Cytotoxic T-cell responses to HIV-1 reverse transcriptase, integrase and protease Aids 12 12 1998 1427 1436
20. E.A. Hehl, P. Joshi, G.V. Kalpana, and V.R. Prasad Interaction between human immunodeficiency virus type 1 reverse transcriptase and integrase proteins J. Virol. 78 10 2004 5056 5067
21. Y. Huang, W.P. Kong, and G.J. Nabel Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression J. Virol. 75 10 2001 4947 4951
22. N. Imami, A. Pires, G. Hardy, J. Wilson, B. Gazzard, and F. Gotch A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection J. Virol. 76 18 2002 9011 9023
23. X. Jin, D.E. Bauer, S.E. Tuttleton, S. Lewin, A. Gettie, J. Blanchard, C.E. Irwin, J.T. Safrit, J. Mittler, L. Weinberger, L.G. Kostrikis, L. Zhang, A.S. Perelson, and D.D. Ho Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques J. Exp. Med. 189 6 1999 991 998
24. R.J. Kaufman, M.V. Davies, L.C. Wasley, and D. Michnick Improved vectors for stable expression of foreign genes in mammalian cells by use of the untranslated leader sequence from EMC virus Nucleic Acids Res. 19 16 1991 4485 4490
25. R. Kaul, T. Dong, F.A. Plummer, J. Kimani, T. Rostron, P. Kiama, E. Njagi, E. Irungu, B. Farah, J. Oyugi, R. Chakraborty, K.S. MacDonald, J.J. Bwayo, A. McMichael, and S.L. Rowland-Jones CD8 (+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects J. Clin. Invest. 107 10 2001 1303 1310
26. R. Kaul, S.L. Rowland-Jones, J. Kimani, K. Fowke, T. Dong, P. Kiama, J. Rutherford, E. Njagi, F. Mwangi, T. Rostron, J. Onyango, J. Oyugi, K.S. MacDonald, J.J. Bwayo, and F.A. Plummer New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers Immunol. Lett. 79 1-2 2001 3 13
27. I. Kiszka, D. Kmieciak, J. Gzyl, T. Naito, E. Bolesta, A. Sieron, S.P. Singh, A. Srinivasan, G. Trinchieri, Y. Kaneko, and D. Kozbor Effect of the V3 loop deletion of envelope glycoprotein on cellular responses and protection against challenge with recombinant vaccinia virus expressing gp160 of primary human immunodeficiency virus type 1 isolates J. Virol. 76 9 2002 4222 4232
28. D. Kmieciak, E. Bolesta, T. Naito, J. Gzyl, Y. Kaneko, and D. Kozbor Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens J. Hum. Virol. 4 6 2001 306 316
29. W.P. Kong, Y. Huang, Z.Y. Yang, B.K. Chakrabarti, Z. Moodie, and G.J. Nabel Immunogenicity of multiple gene and clade human immunodeficiency virus type 1 DNA vaccines J. Virol. 77 23 2003 12764 12772
30. B. Korber, B. Gaschen, K. Yusim, R. Thakallapally, C. Kesmir, and V. Detours Evolutionary and immunological implications of contemporary HIV-1 variation Br. Med. Bull. 58 2001 19 42
31. B.T.M. Korber, J.P. Moore, C. Brander, B.D. Walker, B.F. Haynes, and R. Koup HIV Molecular Immunology Database 2002 Theoretical Biology and Biophysics, Los Alamos National Library Los Alamos, NM
32. B.T.M. Korber, J.P. Moore, C. Brander, B.D. Walker, B.F. Haynes, and R. Koup HIV Molecular Immunology Database 2003 Theoretical Biology and Biophysics, Los Alamos National Library Los Alamos, NM
33. R.A. Koup, J.T. Safrit, Y. Cao, C.A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D.D. Ho Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome J. Virol. 68 7 1994 4650 4655
34. K. Luzuriaga, D. Holmes, A. Hereema, J. Wong, D.L. Panicali, and J.L. Sullivan HIV-1-specific cytotoxic T lymphocyte responses in the first year of life J. Immunol. 154 1 1995 433 443
35. A.J. McMichael, and S.L. Rowland-Jones Cellular immune responses to HIV Nature 410 6831 2001 980 987
36. Y. Miyahira, K. Murata, D. Rodriguez, J.R. Rodriguez, M. Esteban, M.M. Rodrigues, and F. Zavala Quantification of antigen specific CD8+ T cells using an ELISPOT assay J. Immunol. Methods 181 1 1995 45 54
37. V. Novitsky, U.R. Smith, P. Gilbert, M.F. McLane, P. Chigwedere, C. Williamson, T. Ndung'u, I. Klein, S.Y. Chang, T. Peter, I. Thior, B.T. Foley, S. Gaolekwe, N. Rybak, S. Gaseitsiwe, F. Vannberg, R. Marlink, T.H. Lee, and M. Essex Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design? J. Virol. 76 11 2002 5435 5451
38. V. Parissi, C. Calmels, V.R. De Soultrait, A. Caumont, M. Fournier, S. Chaignepain, and S. Litvak Functional interactions of human immunodeficiency virus type 1 integrase with human and yeast HSP60 J. Virol. 75 23 2001 11344 11353
39. J.T. Qiu, B. Liu, C. Tian, G.N. Pavlakis, and X.F. Yu Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway J. Virol. 74 13 2000 5997 6005
40. E.S. Rosenberg, J.M. Billingsley, A.M. Caliendo, S.L. Boswell, P.E. Sax, S.A. Kalams, and B.D. Walker Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia Science 278 5342 1997 1447 1450
41. S.L. Rowland-Jones, T. Dong, K.R. Fowke, J. Kimani, P. Krausa, H. Newell, T. Blanchard, K. Ariyoshi, J. Oyugi, E. Ngugi, J. Bwayo, K.S. MacDonald, A.J. McMichael, and F.A. Plummer Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi J. Clin. Invest. 102 9 1998 1758 1765
42. J.E. Schmitz, M.J. Kuroda, S. Santra, V.G. Sasseville, M.A. Simon, M.A. Lifton, P. Racz, K. Tenner-Racz, M. Dalesandro, B.J. Scallon, J. Ghrayeb, M.A. Forman, D.C. Montefiori, E.P. Rieber, N.L. Letvin, and K.A. Reimann Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes Science 283 5403 1999 857 860
43. A. Seth, I. Ourmanov, J.E. Schmitz, M.J. Kuroda, M.A. Lifton, C.E. Nickerson, L. Wyatt, M. Carroll, B. Moss, D. Venzon, N.L. Letvin, and V.M. Hirsch Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge J. Virol. 74 6 2000 2502 2509
44. H.F. Staats, W.G. Nichols, and T.J. Palker Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN (A) J. Immunol. 157 1 1996 462 472
45. B.D. Walker, and B.T. Korber Immune control of HIV: the obstacles of HLA and viral diversity Nat. Immunol. 2 6 2001 473 475
46. T.J. Wasik, J. Bratosiewicz, A. Wierzbicki, V.E. Whiteman, R.R. Rutstein, S.E. Starr, S.D. Douglas, D. Kaufman, A.V. Sison, M. Polansky, H.W. Lischner, and D. Kozbor Protective role of beta-chemokines associated with HIV-specific Th responses against perinatal HIV transmission J. Immunol. 162 7 1999 4355 4364
47. W. Wilson, M. Braddock, S.E. Adams, P.D. Rathjen, S.M. Kingsman, and A.J. Kingsman HIV expression strategies: ribosomal frameshifting is directed by a short sequence in both mammalian and yeast systems Cell 55 6 1988 1159 1169
48. C.C. Wilson, D. McKinney, M. Anders, S. MaWhinney, J. Forster, C. Crimi, S. Southwood, A. Sette, R. Chesnut, M.J. Newman, and B.D. Livingston Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1 J. Immunol. 171 10 2003 5611 5623
49. B.J. Winer Design and analysis of factorial experiments Statistical Principles in Experimental Design 2nd ed. 1971 McGraw-Hill New York 224 251
50. T. Woodberry, J. Gardner, L. Mateo, D. Eisen, J. Medveczky, I.A. Ramshaw, S.A. Thomson, R.A. Ffrench, S.L. Elliott, H. Firat, F.A. Lemonnier, and A. Suhrbier Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIV CD8(+) cytotoxic T-cell epitopes J. Virol. 73 7 1999 5320 5325
51. M.S. Wyand, K.H. Manson, A.A. Lackner, and R.C. Desrosiers Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus Nat. Med. 3 1 1997 32 36
52. X.G. Yu, H. Shang, M.M. Addo, R.L. Eldridge, M.N. Phillips, M.E. Feeney, D. Strick, C. Brander, P.J. Goulder, E.S. Rosenberg, B.D. Walker, and M. Altfeld Important contribution of p15 Gag-specific responses to the total Gag-specific CTL responses Aids 16 3 2002 321 328
53. K. Yusim, C. Kesmir, B. Gaschen, M.M. Addo, M. Altfeld, S. Brunak, A. Chigaev, V. Detours, and B.T. Korber Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation J. Virol. 76 17 2002 8757 8768
54. J. zur Megede, G.R. Otten, B. Doe, H. Liu, L. Leung, J.B. Ulmer, J.J. Donnelly, and S.W. Barnett Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccines J. Virol. 77 11 2003 6197 6207